US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Ongoing

Infla-650 Herbal Dietary Supplement

Reason Marketed without an approved NDA/ANDA: FDA analysis found product to be tainted with undeclared acetaminophen, diclofenac, and phenylbutazone.

Guru Inc. D-0666-2024
Class III · Low risk Ongoing

Sevelamer Carbonate for Oral Suspension 0.8g packets

Reason Labeling: Incorrect or Missing Lot and/or Exp Date. Missing lot number and expiration dates on packets

Dr. Reddy's Laboratories, Inc. NDC 43598-478-90 D-0625-2024
Class II · Moderate risk Terminated

Potassium Chloride Micro 10mEq K

Reason CGMP Deviations: Out of specification for dissolution

RemedyRepack Inc. NDC 70518-1203-03 D-0611-2024
Class II · Moderate risk Terminated

Blemfree All Day Lotion

Reason CGMP Deviations: Manufactured without following Current Good Manufacturing Practises.

Equibal Inc NDC 53228-002-01 D-0591-2024
Class II · Moderate risk Completed

Budesonide

Reason CGMP Deviations and Presence of Particulate Matter: Glass

Medisca Inc. D-0570-2024
Class III · Low risk Ongoing

Hemp Bombs CBD Pain Freeze

Reason Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.

Global Widget LLC D-0616-2024
Class III · Low risk Ongoing

Hemp Bombs CBD Pain Freeze

Reason Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.

Global Widget LLC D-0615-2024
Class III · Low risk Ongoing

Hemp Bombs CBD Pain Freeze

Reason Subpotent drug: The potency of the active (menthol) was less than the label claim of 4%.

Global Widget LLC NDC 73423-003-01 D-0613-2024
Class III · Low risk Ongoing

Diflorasone Diacetate Ointment

Reason Failed Impurities/Degradation Specifications: The impurity results at 12 months stability testing,did not conform to the specification limit.

Rising Pharma Holding, Inc. NDC 64980-124-60 D-0599-2024
Class III · Low risk Ongoing

SinuFrin Decongestant

Reason Sub-potent Drug

Neilmed Pharmaceuticals Inc NDC 13709-325-01 D-0569-2024
Class I · High risk Terminated

Acetaminophen Extra Strength Tablets

Reason Labeling: Label Mix-Up: Some bottles of Acetaminophen Extra Strength 500 mg tablets were incorrectly labeled with the drug facts label for Aspirin 81 mg tablets.

A-S Medication Solutions LLC D-0631-2024
Class II · Moderate risk Terminated

Venlafaxine Hydrochloride Extended-Release Capsules

Reason Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.

Zydus Pharmaceuticals (USA) Inc NDC 68382-034-16 D-0617-2024
Class II · Moderate risk Ongoing

Little Moon Essentials

Reason CGMP deviations

Little Moon Essentials LLC NDC 70722-319-02 D-0578-2024
Class II · Moderate risk Ongoing

Little Moon Essentials

Reason CGMP deviations

Little Moon Essentials LLC NDC 70722-216-05 D-0577-2024
Class II · Moderate risk Ongoing

Little Moon Essentials

Reason CGMP deviations

Little Moon Essentials LLC NDC 70722-208-05 D-0576-2024
Class II · Moderate risk Ongoing

Little Moon Essentials

Reason CGMP deviations

Little Moon Essentials LLC NDC 70722-229-05 D-0575-2024
Class II · Moderate risk Ongoing

Little Moon Essentials

Reason CGMP deviations

Little Moon Essentials LLC NDC 70722-232-02 D-0574-2024
Class II · Moderate risk Ongoing

Little Moon Essentials

Reason CGMP deviations

Little Moon Essentials LLC NDC 70722-203-05 D-0573-2024
Class II · Moderate risk Ongoing

Little Moon Essentials

Reason CGMP deviations

Little Moon Essentials LLC NDC 70722-260-04 D-0572-2024
Class II · Moderate risk Ongoing

Little Moon Essentials

Reason CGMP deviations

Little Moon Essentials LLC NDC 70722-246-02 D-0571-2024
Class II · Moderate risk Terminated

Venlafaxine Hydrochloride

Reason Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories NDC 0904-7075-61 D-0584-2024